Connect with us

Health

COVID-19 – Italy Records 10,779 Deaths, 97,689 Infection Cases

Published

on

The COVID-19 outbreak in Italy has now claimed 10,779 lives with a cumulative number of 97,689 cases, according to the Department of Public Protection on Sunday.

A total of 756 COVID-19 patients died within the last 24 hours, Xinhua news agency reported.

The total number of patients treated in the intensive care unit was 3, 906.

Source: BERNAMA

Health

COVID-19 Vaccine In Line With Means To Prevent Diseases, Avoid Harm – Jakim

Published

on

KUALA LUMPUR, Jan 19 — The use of the COVID-19 vaccine is in line with Islamic law as a means to prevent diseases as well as to protect others from harm.

A research officer in the Prime Minister’s Department (Religious Affairs) Fahmi Rusli said the vaccination is necessary for those who have been identified by the government, among them the frontline workers and high risk groups including the elderly.

“The COVID-19 vaccination is similar to the administration of injected vaccines on babies to prevent the spread of various diseases such as polio and so forth,” he said when appearing as guest in the Tanya Jakim segment titled `What’s With the COVID-19 Vaccine’ which was live-streamed on the Department of Islamic Development Malaysia (Jakim) Facebook page today.

Fahmi said, Islam promotes disease prevention as according to a hadith from Prophet Muhammad SAW it was mentioned that “He who eats seven ajwa dates every morning, will not be affected by poison or magic on the day he eats them.”

He said, Islam encourages its followers to prevent diseases or seek treatment early before a disease is spread to others, adding that refusing to take the COVID-19 vaccine can cause a person to infect others and this is contrary to Islamic teachings.

Earlier, Bernama reported that the Special Muzakarah Committee of the National Council for Islamic Religious Affairs had agreed that the use of COVID-19 vaccine is compulsory for groups that have been identified by the government and permissible for others.

Minister in the Prime Minister’s Department (Religious Affairs), Senator Datuk Seri Dr Zulkifli Mohamad Al-Bakri was quoted as saying that the ruling had been communicated to the Conference of Rulers.

Prime Minister Tan Sri Muhyiddin Yassin when announcing the Malaysian Economic and Rakyat’s Protection Assistance Package (PERMAI) on Monday said the government expects  to receive the first batch of vaccines by the end of February with the first  group to be vaccinated      by early March.

The COVID-19 vaccination programme will run in stages over a 12-month period and almost 27 million or over 80 per cent of the population are expected to receive the vaccine by the first quarter of next year.

Sources: BERNAMA

Continue Reading

Health

A Baby Survives COVID-19 And Liver Transplant Just Before His 1st Birthday

Published

on

By

Having survived both COVID-19 and a liver transplant, both before his first birthday, Kasen Donerlson is considered a “miracle baby.”

“It’s been very, very stressful,” Kasen’s mom, Mitayah Donerlson, told “Good Morning America.”

“But his recovery right now is going so sweet and so smooth that I can’t ask for anything more.”

Kasen, of Syracuse, New York, was born, according to Donerlson, on Jan. 14, 2020, weighing a healthy eight pounds. Due to respiratory problems and jaundice, he spent a few days in the neo-natal intensive care unit (NICU), which Donerlson said doctors told her would change as he grew older.

Donerlson said she pursued further tests for her son when Kasen’s health did not improve. The baby was diagnosed with a serious case of biliary atresia around two months after his birth, a disorder in which, according to the National Institute of Diabetes and Digestive and Kidney Diseases, bile ducts in and around the liver are scarred and blocked (NIDDK).

Kasen underwent emergency surgery just a few days after his diagnosis to restore his bile ducts. But the operation proved ineffective, according to Donerlson, who soon discovered that a liver transplant would be necessary for her son.

“We had endless hospital visits and we would be there for five or seven or 10 days because of the severity of the disease and the complications that Kasen was having,” said Donerlson, adding that Kasen had to be placed on a feeding tube. “He would have fevers that wouldn’t come down.”

At UPMC Children’s Hospital of Pittsburgh, about a five-hour drive from the family’s Syracuse home, Donerlson, who also cares for her 4-year-old son and 5-year-old niece, was able to get Kasen on the transplant waiting list.

In November, Donerlson said she, her significant other, her niece, and Kasen all tested positive for COVID-19 as Kasen was waiting for a liver to become available.

According to Donerlson, who, along with her family members, did not experience any complications from COVID-19, Kasen spent about three days in the hospital, but his only complication was a fever.

Just two weeks later, at the beginning of December, Donerlson received the call she’d been waiting for for months—that Kasen had a liver.

According to Dr. George Mazariegos, chief of Pediatric Transplantation at UPMC Children’s Hospital of Pittsburgh, when Kasen underwent the transplant in early January, he weighed just about 10 pounds more than his birth weight.

After the nearly 10-hour transplant operation, Donerlson said she found an instant improvement in Kasen.

Prior to his first birthday, Kasen Donerlson, of Syracuse, N.Y., survived both COVID-19 and a liver transplant.

Kasen is supposed to have a long, normal, and healthy life with his new liver after he spent most of his first life sick and hospitalized, according to Maraziegos.

On Jan. 14, he celebrated his first hospital birthday and is now gaining weight. Donerlson described him as more active and “perkier”post-transplant.

“They made a way for Kasen, a way for my baby, to have a second chance at life, a life that he was not promised to see,” said Donerlson. “I’m just thankful for them.”

Source: Good Morning America

Continue Reading

Health

MOH Committed To Ensuring Safety Of Registered Vaccines

Published

on

KUALA LUMPUR, Jan 18 — The Ministry of Health (MOH) is always committed to ensuring the quality, safety and effectiveness of vaccines and registered medicines are always guaranteed through the quality product monitoring program and also the pharmacovigilance.

Its Minister Datuk Seri Dr Adham Baba, in a statement today said the ministry would notify the public of the latest developments on the registered vaccines, from time to time.

“Those who experience adverse effects after receiving a vaccine can lodge reports to any healthcare facilities that administer vaccines or submit them to NPRA (the National Pharmaceutical Regulatory Division) through its website at https://npra.gov.my,” he said.

He was commenting on a report by the Norwegian Medicines Agency (NMA) on the death cases associated with the Pfizer-BioNTech vaccine in Norway.

Dr Adham said NPRA is seeking detailed information from Pfizer (M) Sdn Bhd as the product registration holder and closely monitoring the development of the issue, including actions taken by other international regulatory bodies such as the European Medicines Agency (EMA).

“Based on the initial report issued by the NMA, the deaths were among the elderly with illnesses and had history of chronic disease.

“Autopsies showed that the recipients (of the vaccine) had suffered fever, nausea and diarrhoea which are normal adverse effects after receiving immunisation and following that vaccination information updates are being carried out to take into account the recipient’s age and health condition,” he said.

Dr Adham said the COVID-19 vaccine produced by Pfizer-BioNTech, COMIRNATY Concentrate For Dispersion For Injection received conditional registration from the Drug Control Authority (PBKD) on Jan 8, this year.

“The efficacy and safety data for this vaccine was obtained from its third phase clinical trials conducted on 44,000 volunteers, including those aged above 75.

“The trials have shown a 95 per cent success rate of the vaccine in preventing symptomatic COVID-19 infection when it is given in two complete doses within 21 days. Clinical research shows that the adverse effects are tolerable and only temporary,” he added.

Sources: BERNAMA

Continue Reading

Trending